Back to search

Article

Genetic Testing for Malignant Hyperthermia Susceptibility – Threading the Needle in the Haystack

2025-08-25

Abstract excerpt

Malignant hyperthermia (MH) is a rare pharmacogenetic disorder triggered by volatile anesthetics and succinylcholine, most often linked to pathogenic variants in RYR1, CACNA1S, and STAC3. The advent of next-generation sequencing (NGS) has transformed MH diagnostics, offering new opportunities for perioperative risk assessment as caffeine-halothane contracture testing declines. However, challenges remain, including...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2219e170-13c0-51fe-be5c-9532654e6dcb
DOI
10.20944/preprints202508.1695.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic Testing for Malignant Hyperthermia Susceptibility – Threading the Needle in the HaystackDOI 10.20944/preprints202508.1695.v1
Select a neighboring publication to make it the new centre.